cancer

The National Institute for Health and Care Excellence (NICE) has advised the NHS against funding for a drug used for advanced ovarian cancer.

Babies and young children are facing serious delays in receiving life-saving treatment because symptoms are being missed by frontline health professionals, Childhood Eye Cancer Trust (CHECT) figures have shown.

Victims of asbestos-related cancer in the workplace will receive increased financial support and benefit from a simpler claims process under a new Bill introduced by the government.

Draft guidance has been issued by the National Institute for Health and Care Excellence (NICE) in an aim to identify more clinically and cost-effective lung cancer treatment.

There are concerns that bowel cancer patients may have their access to vital drugs cut off in January 2014 when the Cancer Drugs Fund (CDF) is due to come to an end.

Reasons for the reported disparity of rising bowel cancer rates among men and women are unknown, Cancer Research UK has said.

Insurers could be facing an increase in declined claims as the complexity of health problems rises, according to the London School of Hygiene and Tropical Medicine.

Cancer waiting lists stand at 18 weeks and stroke care in London is being re-structured, a Committee of Public Accounts report into NHS efficiency has said.

Two out of five clients will decline taking out life cover even after full explanation of the insurance and its benefits, a chartered financial planner has said.

Demand for breast cancer gene testing as a preventative measure is rising and emerging tests may be a key factor in supporting financially-troubled state healthcare systems, a research and consulting firm has reported.